Registration

HOOPER, LUNDY & BOOKMAN, P.C. for GOVERNMENT COUNSEL, LLC (OBO) LUPIN PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Electronic drug labeling, drug take back program and USPTO inter partes review procedure.

LobbyistCovered position, as disclosed
MARTIN A CORRY New —
LISA LAYMAN New CBO, PA(92-96); LA, Sen Chafee(97-99); LA, Sen Bryan(00); SPA, Sen Graham(01-04); SPA, Sen Stabenow(05-07)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
LUPIN LTD. Indonesia Indonesia 100.0% —

Affiliated organisations

OrganisationLocation
LUPIN PHARMACEUTICALS, INC. Baltimore, MD, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.